Basit öğe kaydını göster

Farber disease clinical impact: Patient reported outcomes as a measure of disease burden

dc.contributor.authorKapoor, Seema
dc.contributor.authorSolyom, Alexander
dc.contributor.authorCrosby, Kathleen
dc.contributor.authorMitchell, John
dc.contributor.authorHarmatz, Paul
dc.contributor.authorSelim, Laila
dc.contributor.authorEl Din, Iman Gamal
dc.contributor.authorMungan, Neslihan
dc.contributor.authorBulut, Fatma
dc.contributor.authorGokcay, Gulden
dc.contributor.authorDi Rocco, Maja
dc.contributor.authorBATU AKAL, EZGİ DENİZ
dc.contributor.authorÖZEN, SEZA
dc.contributor.authorSundberg, Erik
dc.contributor.authorMagnusson, Bo
dc.contributor.authorLampe, Christina
dc.contributor.authorGrant, Christina L.
dc.contributor.authorHahn, Andreas
dc.contributor.authorFerreira, Carlos R.
dc.contributor.authorPuri, Ratna D.
dc.contributor.authorBijarnia-Mahay, Sunita
dc.contributor.authorARSLAN, NUR
dc.contributor.authorGuelbert, Norberto
dc.contributor.authorZaki, Maha S.
dc.date.accessioned2022-07-04T12:53:11Z
dc.date.available2022-07-04T12:53:11Z
dc.date.issued2022
dc.identifier.citationMitchell J., Harmatz P., Selim L., El Din I. G. , Mungan N., Bulut F., Lampe C., Grant C. L. , Ferreira C. R. , Puri R. D. , et al., "Farber disease clinical impact: Patient reported outcomes as a measure of disease burden", MOLECULAR GENETICS AND METABOLISM, cilt.135, sa.2, 2022
dc.identifier.issn1096-7192
dc.identifier.othervv_1032021
dc.identifier.otherav_30701555-2c28-4ed5-aed1-81e7ade78aa6
dc.identifier.urihttp://hdl.handle.net/20.500.12627/182173
dc.identifier.urihttps://doi.org/10.1016/j.ymgme.2021.11.216
dc.language.isoeng
dc.subjectEndocrinology
dc.subjectENDOKRİNOLOJİ VE METABOLİZMA
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectGENETİK VE HAYAT
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTIP, ARAŞTIRMA VE DENEYSEL
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectEndokrinoloji ve Metabolizma Hastalıkları
dc.subjectTıbbi Genetik
dc.subjectTıbbi Ekoloji ve Hidroklimatoloji
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectTemel Bilimler
dc.subjectGenetics
dc.subjectMolecular Biology
dc.subjectEndocrine and Autonomic Systems
dc.subjectReviews and References (medical)
dc.subjectGenetics (clinical)
dc.subjectResearch and Theory
dc.subjectEndocrinology, Diabetes and Metabolism
dc.subjectLife Sciences
dc.subjectHealth Sciences
dc.titleFarber disease clinical impact: Patient reported outcomes as a measure of disease burden
dc.typeMakale
dc.relation.journalMOLECULAR GENETICS AND METABOLISM
dc.contributor.departmentMcGill University , ,
dc.identifier.volume135
dc.identifier.issue2
dc.contributor.firstauthorID3431225


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster